WhiteLab Genomics
Morgane Colléaux-Royer has a diverse work experience spanning different roles and companies. Morgane currently works at WhiteLab Genomics as a Product Manager, where they are responsible for creating and implementing scientific and technical project management processes. Morgane also serves as Scrum Master for scientific projects and manages the company's marketing and communication strategy. In addition, they design product strategies for multiple departments within the company.
Prior to their current role, Morgane worked at Sanofi as a Digital innovation ecosystem product owner. In this position, they developed and managed a global startup referencing platform and participated in the co-construction of service offerings for Sanofi and startups. Morgane also played a role in selecting accelerated startups for Future4Care, a digital health startup accelerator.
Before joining Sanofi, Morgane worked at Audioptic Trade Services as a Digital and CSR product owner, focusing on digital and corporate social responsibility initiatives. Morgane previously held the position of Dispensing optician and shop manager at Royer Opticiens Nantes.
Overall, Morgane has demonstrated expertise in project management, product strategy, and digital innovation across various industries.
Morgane Colléaux-Royer's education history is as follows:
From 2021 to 2022, Morgane studied at CentraleSupélec and obtained a Mastère degree in Innovation et transformation.
Between 2019 and 2021, Morgane attended OMNES Education and completed a Master of Science (MS) degree in Strategie de communication.
From 2018 to 2019, Morgane studied at the Institut Supérieur Optique and obtained a Bachelor degree in management, gestion droit, with a focus on Optique.
From 2016 to 2018, Morgane also attended the Institut Supérieur Optique and completed a BTS degree in Optique.
In addition to their formal education, Morgane has earned the TOEIC certification from the TOEIC® Program in 2019.
This person is not in any teams
This person is not in any offices
WhiteLab Genomics
WhiteLab Genomics develops a proprietary platform that leverages graph knowledge technology and machine learning to help companies discover and design new genomic therapies. WhiteLab Genomics enables genomic medicine scientists to obtain precise and comprehensive answers to key scientific and technological questions such as optimizing payload andvector design, assessing genotoxicity, and identifying optimal experimental protocols for in vivo and in vitro strategies. Whitelab Genomics guides its clients through the in-silico development phases, allowing them to quickly develop target vectors and payloads while saving valuable time needed to provide patients with access to new genomic therapies.